Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein
- DOI
- 10.31557/apjcp.2025.26.8.3053
- Published
- 2025-08-01
- Container
- Asian Pacific Journal of Cancer Prevention
- Publisher
- EpiSmart Science Vector Ltd
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.31557/apjcp.2025.26.8.3053,
title = {Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein},
author = {Buthaina Yousif and Doaa Abd Alwahab and Haneen Mohammed and Youssef Yasin and Azal Jumaa},
year = {2025},
journal = {Asian Pacific Journal of Cancer Prevention},
doi = {10.31557/apjcp.2025.26.8.3053},
url = {https://doi.org/10.31557/apjcp.2025.26.8.3053}
}RIS
TY - JOUR TI - Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein AU - Buthaina Yousif AU - Doaa Abd Alwahab AU - Haneen Mohammed AU - Youssef Yasin AU - Azal Jumaa PY - 2025 JO - Asian Pacific Journal of Cancer Prevention DO - 10.31557/apjcp.2025.26.8.3053 UR - https://doi.org/10.31557/apjcp.2025.26.8.3053 ER -
APA
Yousif, B., Alwahab, D. A., Mohammed, H., Yasin, Y., & Jumaa, A. (2025). Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein. Asian Pacific Journal of Cancer Prevention. https://doi.org/10.31557/apjcp.2025.26.8.3053
Source records
- crossref · retrieved 2026-09-25T22:47:43.398Z